Kévin Bihan

979 total citations · 1 hit paper
39 papers, 572 citations indexed

About

Kévin Bihan is a scholar working on Oncology, Pharmacology and Neurology. According to data from OpenAlex, Kévin Bihan has authored 39 papers receiving a total of 572 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 8 papers in Pharmacology and 7 papers in Neurology. Recurrent topics in Kévin Bihan's work include Pharmacovigilance and Adverse Drug Reactions (7 papers), Drug-Induced Adverse Reactions (6 papers) and Cancer Immunotherapy and Biomarkers (6 papers). Kévin Bihan is often cited by papers focused on Pharmacovigilance and Adverse Drug Reactions (7 papers), Drug-Induced Adverse Reactions (6 papers) and Cancer Immunotherapy and Biomarkers (6 papers). Kévin Bihan collaborates with scholars based in France, United States and Italy. Kévin Bihan's co-authors include Joe‐Elie Salem, Bénédicte Lebrun‐Vignes, Christian Funck‐Brentano, Mathieu Kernéis, Javid J. Moslehi, Nicolas Weiss, Fabien Reyal, Floriane Jochum, Paul Gougis and Anne‐Sophie Hamy and has published in prestigious journals such as Nature Communications, Annals of Oncology and European Respiratory Journal.

In The Last Decade

Kévin Bihan

36 papers receiving 557 citations

Hit Papers

Clinical spectrum and evo... 2024 2026 2024 20 40 60
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Clinical spectrum and evolution of immune-checkpoint inhibitors toxicities over a decade—a worldwide perspective
    2024 67 citations Paul Gougis, Floriane Jochum et al. EClinicalMedicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kévin Bihan France 13 169 108 85 71 69 39 572
Masayuki Chuma Japan 14 196 1.2× 45 0.4× 73 0.9× 66 0.9× 22 0.3× 50 522
Christine Le Beller France 13 63 0.4× 46 0.4× 63 0.7× 71 1.0× 42 0.6× 23 513
Carlos Alves Portugal 18 166 1.0× 62 0.6× 136 1.6× 25 0.4× 156 2.3× 54 1.2k
Nassim Djebli France 14 158 0.9× 36 0.3× 77 0.9× 65 0.9× 17 0.2× 30 678
Miguel Gil Spain 13 50 0.3× 156 1.4× 119 1.4× 73 1.0× 49 0.7× 37 643
Kathrin I. Foerster Germany 13 55 0.3× 198 1.8× 77 0.9× 66 0.9× 14 0.2× 39 651
Pauline Bosco‐Lévy France 13 61 0.4× 64 0.6× 36 0.4× 72 1.0× 30 0.4× 31 399
Long Meng China 13 68 0.4× 47 0.4× 47 0.6× 44 0.6× 36 0.5× 31 379
Françoise Livio Switzerland 11 116 0.7× 19 0.2× 47 0.6× 67 0.9× 68 1.0× 53 552
Maria Giuseppa Sullo Italy 11 32 0.2× 52 0.5× 71 0.8× 33 0.5× 64 0.9× 22 397

Countries citing papers authored by Kévin Bihan

Since Specialization
Citations

This map shows the geographic impact of Kévin Bihan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kévin Bihan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kévin Bihan more than expected).

Fields of papers citing papers by Kévin Bihan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kévin Bihan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kévin Bihan. The network helps show where Kévin Bihan may publish in the future.

Co-authorship network of co-authors of Kévin Bihan

This figure shows the co-authorship network connecting the top 25 collaborators of Kévin Bihan. A scholar is included among the top collaborators of Kévin Bihan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kévin Bihan. Kévin Bihan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Weiss, Nicolas, Joe‐Elie Salem, Charles Joussain, et al.. (2025). Real-life prognosis of neurological complications of botulinum toxin: A nationwide pharmacovigilance study of adverse drug reactions reported in France between 1994 and 2020. Annals of Physical and Rehabilitation Medicine. 68(3). 101924–101924.
3.
Laurent, L. J. M., Baptiste Abbar, Kévin Bihan, et al.. (2025). Comedications Associated with Immune‐Related Adverse Events from Immune‐Checkpoint Inhibitors. Clinical Pharmacology & Therapeutics. 118(3). 593–599. 4 indexed citations
4.
Cabannes‐Hamy, Aurélie, Floriane Jochum, Kévin Bihan, et al.. (2025). BCR::ABL1 Tyrosine Kinase Inhibitors During Pregnancy, a Disproportionality Analysis of Vigibase. Clinical Pharmacology & Therapeutics. 118(3). 705–714.
5.
Lebrun-Vignes, Bénédicte, Kamel Masmoudi, Thierry Vial, et al.. (2025). Vaccines and the risk of Guillain-Barré syndrome: A French pharmacovigilance analysis. Therapies. 80(5). 580–588. 1 indexed citations
6.
Beltramo, Guillaume, Christine Le Beller, Kévin Bihan, et al.. (2024). Diffuse lung diseases ascribed to drugs: a nationwide observational study over 37 years using the French Pharmacovigilance Database. European Respiratory Journal. 65(2). 2400756–2400756. 2 indexed citations
7.
Gougis, Paul, Floriane Jochum, Baptiste Abbar, et al.. (2024). Clinical spectrum and evolution of immune-checkpoint inhibitors toxicities over a decade—a worldwide perspective. EClinicalMedicine. 70. 102536–102536. 67 indexed citations breakdown →
8.
9.
Bihan, Kévin, et al.. (2023). Nirmatrelvir/ritonavir (Paxlovid®): French pharmacovigilance survey 2022. Therapies. 78(5). 531–547. 9 indexed citations
10.
Bihan, Kévin, Corinne Isnard Bagnis, Noël Zahr, et al.. (2023). Management of cancer treatments in hemodialysis patients. Bulletin du Cancer. 111(7-8). 701–719. 2 indexed citations
11.
Bompaire, Flavie, Cristina Birzu, Kévin Bihan, et al.. (2023). Advances in treatments of patients with classical and emergent neurological toxicities of anticancer agents. Revue Neurologique. 179(5). 405–416. 3 indexed citations
12.
Bihan, Kévin, et al.. (2022). Drugs associated with posterior reversible encephalopathy syndrome, a worldwide signal detection study. Journal of Neurology. 270(2). 975–985. 12 indexed citations
13.
Bihan, Kévin, et al.. (2022). Drug-induced antiphospholipid syndrome: Analysis of the WHO international database. Autoimmunity Reviews. 21(5). 103060–103060. 6 indexed citations
14.
Bihan, Kévin, Flavie Bompaire, Caroline Houillier, et al.. (2021). Leukoencephalopathy with transient splenial lesions related to 5‐fluorouracil or capecitabine. European Journal of Neurology. 28(7). 2396–2402. 4 indexed citations
15.
Maatoug, Redwan, Kévin Bihan, Philibert Duriez, et al.. (2021). Non-invasive and invasive brain stimulation in alcohol use disorders: A critical review of selected human evidence and methodological considerations to guide future research. Comprehensive Psychiatry. 109. 152257–152257. 12 indexed citations
16.
17.
Kernéis, Mathieu, Kévin Bihan, & Joe‐Elie Salem. (2021). COVID-19 vaccines and myocarditis. Archives of cardiovascular diseases. 114(6-7). 515–517. 22 indexed citations
18.
Bihan, Kévin, Bénédicte Lebrun‐Vignes, Christian Funck‐Brentano, & Joe‐Elie Salem. (2020). Uses of pharmacovigilance databases: An overview. Therapies. 75(6). 591–598. 114 indexed citations
19.
Bihan, Kévin, Nicolas Weiss, Hélène Théophile, Christian Funck‐Brentano, & Bénédicte Lebrun‐Vignes. (2019). Drug‐induced aseptic meningitis: 329 cases from the French pharmacovigilance database analysis. British Journal of Clinical Pharmacology. 85(11). 2540–2546. 21 indexed citations
20.
Bihan, Kévin, et al.. (2014). Simultaneous determination of rivaroxaban and dabigatran levels in human plasma by high-performance liquid chromatography–tandem mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis. 100. 230–235. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Masayuki Chuma Breakdown of academic impact, for papers by Christine Le Beller Breakdown of academic impact, for papers by Carlos Alves Breakdown of academic impact, for papers by Nassim Djebli Breakdown of academic impact, for papers by Miguel Gil Breakdown of academic impact, for papers by Kathrin I. Foerster Breakdown of academic impact, for papers by Pauline Bosco‐Lévy Breakdown of academic impact, for papers by Long Meng Breakdown of academic impact, for papers by Françoise Livio Breakdown of academic impact, for papers by Maria Giuseppa Sullo
Rankless by CCL
2026